| scholarly article | Q13442814 |
| P2093 | author name string | Norman J Haughey | |
| Susan A Masino | |||
| Thad A Rosenberger | |||
| Jonathan D Geiger | |||
| Liang Hui | |||
| Xuesong Chen | |||
| Dhaval Bhatt | |||
| Nicholas H Geiger | |||
| P2860 | cites work | MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis | Q24301992 |
| The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies | Q24646616 | ||
| Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 | Q24673389 | ||
| HIV-1 associated dementia: symptoms and causes | Q27473387 | ||
| HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization | Q27487322 | ||
| Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria | Q72593109 | ||
| In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS | Q72687052 | ||
| Tat mediates apoptosis in vivo in the rat central nervous system | Q73330035 | ||
| Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism | Q79810628 | ||
| Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications | Q79869481 | ||
| Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat | Q28145171 | ||
| Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages | Q28145895 | ||
| Mitochondrial control of cell death induced by HIV-1-encoded proteins | Q28200272 | ||
| HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity | Q28210557 | ||
| HIV tat and neurotoxicity | Q28239973 | ||
| Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum | Q28250735 | ||
| HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells | Q28252348 | ||
| Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells | Q28289237 | ||
| Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity | Q28298642 | ||
| Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine | Q28369859 | ||
| A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases | Q28477511 | ||
| Control of glucose utilization in working perfused rat heart | Q28579696 | ||
| The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders | Q30411844 | ||
| Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. | Q33594713 | ||
| Mitochondria and neuronal survival | Q33807218 | ||
| Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes | Q33817233 | ||
| HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities | Q34037622 | ||
| Ketone bodies, potential therapeutic uses | Q34092390 | ||
| HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. | Q34095509 | ||
| Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid | Q34280603 | ||
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study | Q34370880 | ||
| The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children | Q34481820 | ||
| Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet | Q34542879 | ||
| Dementia and neurocognitive disorders due to HIV-1 infection | Q34602429 | ||
| Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior | Q34711201 | ||
| HIV neurotoxicity: potential therapeutic interventions | Q34795283 | ||
| Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. | Q34978071 | ||
| Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia | Q34993084 | ||
| A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors | Q35572467 | ||
| HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes | Q35652521 | ||
| Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic | Q35856188 | ||
| D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease | Q35919815 | ||
| HIV dementia: an evolving disease | Q35972797 | ||
| Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. | Q47931417 | ||
| D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA. | Q48236505 | ||
| HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress | Q48313745 | ||
| HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. | Q48319980 | ||
| The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load | Q48485626 | ||
| Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides | Q48824185 | ||
| Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum | Q48877809 | ||
| Permeability of the blood-brain barrier to HIV-1 Tat. | Q48938059 | ||
| The ketogenic diet and epilepsy | Q56431461 | ||
| [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system] | Q58000811 | ||
| Extraction and measurement of myocardial nucleotides, nucleosides, and purine bases by high-performance liquid chromatography | Q68404881 | ||
| Cell death in HIV dementia | Q36068289 | ||
| Cerebral ketone body metabolism | Q36118288 | ||
| Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity | Q36148402 | ||
| Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein | Q36202870 | ||
| Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease | Q36633918 | ||
| Insulin, ketone bodies, and mitochondrial energy transduction. | Q36706028 | ||
| Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity | Q36800065 | ||
| D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease | Q36976707 | ||
| Calcium in cell injury and death | Q37014795 | ||
| Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary cultures | Q37189865 | ||
| The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era | Q37193610 | ||
| PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium | Q37366558 | ||
| Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study | Q37584886 | ||
| A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection | Q37617639 | ||
| Acetoacetate protects neuronal cells from oxidative glutamate toxicity | Q40325330 | ||
| Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells. | Q40372338 | ||
| The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. | Q40447137 | ||
| Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase | Q40518676 | ||
| Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport | Q40674779 | ||
| The role of monoamine metabolism in oxidative glutamate toxicity. | Q41158837 | ||
| Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. | Q41335848 | ||
| Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources | Q41721709 | ||
| Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons | Q41869742 | ||
| Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation | Q42085329 | ||
| Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors | Q42177440 | ||
| Variable progression of HIV-associated dementia | Q42456961 | ||
| Ketone bodies are protective against oxidative stress in neocortical neurons | Q42510499 | ||
| Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function | Q42527671 | ||
| Acetoacetate as regulator of palmitic acid-induced uncoupling involving liver mitochondrial ADP/ATP antiporter and aspartate/glutamate antiporter. | Q42969628 | ||
| D-beta-hydroxybutyrate prevents MPP+-induced neurotoxicity in PC12 cells | Q43256162 | ||
| Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats | Q43793315 | ||
| HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells | Q44320785 | ||
| Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site | Q44459049 | ||
| Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. | Q44532198 | ||
| The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site | Q44673435 | ||
| Excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons. | Q44939763 | ||
| Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment | Q45194007 | ||
| Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins | Q45403949 | ||
| Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits | Q45445627 | ||
| Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. | Q45757726 | ||
| Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. | Q45763749 | ||
| Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. | Q45995997 | ||
| Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons. | Q46003859 | ||
| NMDA receptor activation by HIV-Tat protein is clade dependent | Q46237608 | ||
| HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. | Q46391202 | ||
| Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor | Q46873640 | ||
| The ketogenic diet increases mitochondrial uncoupling protein levels and activity | Q47866548 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ketone bodies | Q746183 |
| neurotoxicity | Q3338704 | ||
| P304 | page(s) | 382-391 | |
| P577 | publication date | 2012-05-17 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Ketone bodies protection against HIV-1 Tat-induced neurotoxicity | |
| P478 | volume | 122 |
| Q36984167 | 5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat. |
| Q34131740 | Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice |
| Q92797381 | BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation |
| Q96350898 | Conditional expression of HIV-1 Tat in the mouse alters the onset and progression of tonic, inflammatory, and neuropathic hypersensitivity in a sex-dependent manner |
| Q35215063 | Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury |
| Q38716297 | DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia |
| Q43598814 | HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. |
| Q92548566 | HIV-1 Tat-Induced Astrocytic Extracellular Vesicle miR-7 Impairs Synaptic Architecture |
| Q92158622 | HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders |
| Q45824470 | Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? |
| Q35440147 | MSM ameliorates HIV-1 Tat induced neuronal oxidative stress via rebalance of the glutathione cycle |
| Q38101560 | Neuronal toxicity in HIV CNS disease |
| Q24293525 | PACAP27 is protective against tat-induced neurotoxicity |
| Q40422651 | Release of calcium from endolysosomes increases calcium influx through N-type calcium channels: Evidence for acidic store-operated calcium entry in neurons |
| Q27025573 | Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders |
| Q52654834 | Scaling Synapses in the Presence of HIV. |
| Q49787444 | TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment |
Search more.